首页> 外文会议>International Conference on New Material and Chemical Industry >Pluronic F127/chitosan blend microspheres for mucoadhesive drug delivery
【24h】

Pluronic F127/chitosan blend microspheres for mucoadhesive drug delivery

机译:Pluronic F127 /壳聚糖混合物微球用于粘膜粘附药物递送

获取原文

摘要

Pluronic F127/chitosan blend microspheres were prepared via emulsification and cross-linking process using glutaraldehyde as a cross-linker. Compared with chitosan microspheres fabricated under the same experimental conditions, blend microspheres exhibited better physical stability and higher swelling capacity. Puerarin, a traditional Chinese medicine, was incorporated into microparticlesas the model drug. The in vitro release of puerarin from blend microspheres was reduced because of the improved compatibility of the drug with the matrices. According to the results from in vitro adhesion experiments, mucoadhesive behavior of blend microspheres on a mucosa-like surface was similar to that of chitosan microspheres, despite their good ability of anti-protein absorption in solution.
机译:通过使用戊二醛作为交联剂,通过乳化和交联过程制备Pluronic F127 /壳聚糖混合物微球。与在相同的实验条件下制造的壳聚糖微球相比,混合微球表现出更好的物理稳定性和更高的膨胀能力。中药葛根素纳入了模型药物的微粒。由于药物与基质的改善,减少了来自混合微球的葛根素的体外释放。根据体外粘附实验的结果,尽管它们在溶液中的抗蛋白质吸收能力良好,但粘膜状表面上混合物微球的粘膜粘附行为与壳聚糖微球的粘膜粘附性相似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号